天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Temsirolimus
162635-04-3

Temsirolimus synthesis

2synthesis methods
Temsirolimus is an ester analog of rapamycin. Temsirolimus binds to and inhibits the mammalian target of rapamycin (mTOR), resulting in decreased expression of mRNAs necessary for cell cycle progression and arresting cells in the G1 phase of the cell cycle. mTOR is a serine/threonine kinase which plays a role in the PI3K/AKT pathway that is upregulated in some tumors. Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007.
Synthetic Routes
  • ROUTE 1
  • 202112073905855782.jpg

    Gu, Jianxin; Ruppen, Mark E.; Raveendranath, Panolil; Chew, Warren; Shaw, Chia-Cheng. Production of rapamycin 42-ester with 2,2-bis(hydroxymethyl)propionic acid (CCI-779) and its proline analog. Assignee Wyeth, USA. US 20050234086. (2005).

  • ROUTE 2
  • 202112070717721435.jpg

    Chew, Warren; Shaw, Chia-cheng. Preparation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779). Assignee Wyeth, USA. US 20050033046. (2005).

  • ROUTE 3
  • 202112073486251099.jpg

    Gupta, Nitin; Handa, Vishal; Pal, Abir Kumar; Singh, Hemant Kumar; Lahiri, Saswata; Dubey, Sushil Kumar. Process for the preparation of temsirolimus and its intermediates. Assignee Fresenius Kabi Oncology Limited, India. US 20110184167. (2011).

  • ROUTE 4
  • 202112076223788846.jpg

    Song, Honghai; Tang, Long; Chen, Wei; Li, Zheng; Li, Jinzhou; Sun, Zhicun; Feng, Jiajin. Process for the preparation of temsirolimus from rapamycin. Assignee Tianjin Weijie Technology Co., Ltd., Peop. Rep. China. US 20130296572. (2013).

  • ROUTE 5
  • 202112078422580788.jpg

    Lee, Kwang-Chung; Lee, Ting-Huei; Tung, Yen-Shih; Kao, Chia-Chen; Lee, Tzu-Ai. Process for preparation of temsirolimus. Assignee Chunghwa Chemical Synthesis & Biotech Co., Ltd., Taiwan. US 20100249415. (2010).

  • ROUTE 6
  • 202112076752408843.jpg

    Cao, Kangping; Sun, Jian; Xie, Yipeng; Liu, Yanxia. Separation and purification method of temsirolimus. Assignee Sichuan Hairong Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, Peop. Rep. China. CN 109851626. (2019).

  • ROUTE 7
  • 202112076809978480.jpg

    He, Zhengquan; Tian, Shan; Huang, Yan. Preparation method of Temsirolimus. Assignee Sichuan Moer Biopharmaceutical Co., Ltd., Peop. Rep. China. CN 107722037. (2018).

202112073905855782.jpg

Gu, Jianxin; Ruppen, Mark E.; Raveendranath, Panolil; Chew, Warren; Shaw, Chia-Cheng. Production of rapamycin 42-ester with 2,2-bis(hydroxymethyl)propionic acid (CCI-779) and its proline analog. Assignee Wyeth, USA. US 20050234086. (2005).

-

Yield:162635-04-3 83.2%

Reaction Conditions:

with sulfuric acid;water in tetrahydrofuran at 0 - 5;

Steps:

2
In a 5L glass reaction bottle,Add coupling intermediate 48g, 1000ml tetrahydrofuran,Stirring temperature control is 0~5 °C,Slowly add 126ml of 2mol/L sulfuric acid solution.After the drop, the temperature is stirred at 0 to 5 ° C,TLC detects the progress of the reaction and the reaction is completed.After that, 500 ml of drinking water was added to the reaction solution.1000ml of ethyl acetate, stirring, liquid separation,Ethyl acetate500ml/time extraction twice,Combine the organic layers with 1000 ml of saturated sodium bicarbonate solution,1000ml saturated saline solutionWashing, drying anhydrous sodium sulfate 300g for 3 to 4 hours; filtering, evaporating ethyl acetate to dryness under reduced pressure to give a pale yellow foamy solid;The yield was 83.2%.

References:

Lunan Pharmaceutical Group Co., Ltd.;Zhang Guimin;Bai Wenqin;Song Chuanling;Sun Xiuling CN108948046, 2018, A Location in patent:Paragraph 0062; 0063; 0068

FullText

Temsirolimus Related Search: